ARHGAP11A and glioblastoma: Nevertheless, we detected increased expression of ARHGAP11A in highly invasive tumor (Figure S13){Kupershmidt, 2010 #428}, and this therapy would therefore be useful for treating highly invasive cancers, chief among them glioblastoma and pancreatic cancer, for which there are currently limited therapeutic approaches.